Immunogen Inc. buy BMO Capital Markets
Start price
01.08.23
/
50%
€16.22
Target price
01.08.24
€23.69
Performance (%)
78.61%
Price
09.02.24
€28.97
Summary
This prediction is currently active. With a performance of 78.61% the BUY prediction by BMO_Capital_Markets is a big success. This prediction currently runs until 01.08.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Immunogen Inc. | - | - |
iShares Core DAX® | -1.189% | -3.063% |
iShares Nasdaq 100 | 3.663% | 8.732% |
iShares Nikkei 225® | -1.422% | -0.414% |
iShares S&P 500 | 2.182% | 4.907% |
Comments by BMO_Capital_Markets for this prediction
In the thread Immunogen Inc. diskutieren
ImmunoGen, Inc. (NASDAQ: IMGN) had its price target raised by analysts at BMO Capital Markets from $25.00 to $26.00. They now have an "outperform" rating on the stock.
Ratings data for IMGN provided by MarketBeat